SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-140443
Filing Date
2020-05-12
Accepted
2020-05-12 16:18:03
Documents
5
Period of Report
2020-05-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d928476d8k.htm 8-K 20325
2 EX-1.1 d928476dex11.htm EX-1.1 167542
3 EX-5.1 d928476dex51.htm EX-5.1 9594
4 GRAPHIC g928476dsp0049.jpg GRAPHIC 1888
5 GRAPHIC g928476dsp049a.jpg GRAPHIC 6131
  Complete submission text file 0001193125-20-140443.txt   209854
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 20869348
SIC: 2834 Pharmaceutical Preparations